What does an INR of 3.5 mean?

An INR of 3.5 means your blood is taking longer to clot than the standard target range of 2.0–3.0 for most conditions. It indicates your warfarin dose may be slightly high, putting you at increased risk of bleeding. Your anticoagulation team will likely recommend a small dose reduction and retest sooner than usual. Do not adjust your dose independently — always follow your clinic's guidance.

What happens if my INR is too low?

An INR below your target range (e.g., below 2.0 for most AF patients) means your blood is clotting more readily than intended — the risk of the condition you are being treated for (stroke, DVT, PE) increases. Your anticoagulation team will increase your warfarin dose and retest. In some cases, bridging anticoagulation with a low molecular weight heparin injection may be considered for high-risk patients.

Can I eat spinach and leafy greens on warfarin?

Yes — eat them consistently rather than avoiding them. Vitamin K in leafy greens (spinach, kale, broccoli, Brussels sprouts) counteracts warfarin. The danger is inconsistency — eating large amounts one week and none the next causes INR swings. If you eat these foods in roughly similar quantities week to week, your INR will be stable and your dose calibrated accordingly. Tell your anticoagulation team about your typical diet.

Should I switch from warfarin to a DOAC?

For most patients with atrial fibrillation or DVT/PE, DOACs (apixaban, rivaroxaban, dabigatran) are now the preferred option because they do not require regular INR monitoring, have fewer food interactions, and have equivalent or superior safety profiles compared to warfarin. However, warfarin remains the anticoagulant of choice for mechanical heart valves and antiphospholipid syndrome — DOACs are not approved for these indications. Ask your doctor or cardiologist whether your specific indication is suitable for a switch.

How often do I need INR testing on warfarin?

Frequency depends on how stable your INR has been. When first starting warfarin or after a dose change, testing is needed every 1–2 weeks. Once stable, many patients test monthly. Some patients with very stable, long-term INR can extend to every 6–8 weeks. If you start a new medication, have an illness, or change your diet significantly, more frequent testing is recommended. Self-monitoring with a home INR device (CoaguChek) is an option for some patients — discuss with your clinic.

Understanding Your INR and Warfarin Results

Quick answer: Your INR (International Normalised Ratio) measures how long your blood takes to clot. Most patients on warfarin have a target INR of 2.0–3.0. An INR below your target means your blood is clotting too quickly (clot risk); above your target means it is clotting too slowly (bleeding risk). Bring a record of your recent INR results, any dose changes, and note any new medications, supplements, or significant dietary changes since your last test.

Warfarin (brand names: Coumadin, Marcumar) is one of the most widely monitored medications in the world — the therapeutic window is narrow and dozens of factors affect INR. Understanding your result gives you the context to have a productive conversation with your anticoagulation clinic, GP, or haematologist.

Get Your Free Appointment Checklist

Join free and download specialist preparation checklists — tell us your specialty for a personalised guide.

Free. No spam. Unsubscribe any time.

What INR Measures

INR measures the time it takes for your blood to form a clot, standardised so results are comparable across different labs. It is derived from the Prothrombin Time (PT) test. A normal INR for someone not on warfarin is approximately 1.0. Warfarin deliberately extends clotting time — hence a therapeutic INR of 2.0–3.0 for most conditions.

INR Target Ranges

Condition	Target INR Range
Atrial fibrillation (AF)	2.0 – 3.0
Deep vein thrombosis (DVT) / Pulmonary embolism (PE)	2.0 – 3.0
Mechanical heart valve (aortic, bileaflet)	2.0 – 3.0
Mechanical heart valve (mitral, older models)	2.5 – 3.5
Antiphospholipid syndrome (high risk)	2.5 – 3.5

What Affects INR — Key Interactions

INR is unusually sensitive to external factors. Report any of the following to your anticoagulation team:

New medications: Antibiotics (especially metronidazole, fluconazole, ciprofloxacin), NSAIDs (ibuprofen, aspirin), amiodarone, antiepileptics, statins, and many others raise or lower INR significantly
Supplements: Fish oil, vitamin E, garlic, ginkgo (raise INR); St John’s Wort, coenzyme Q10, green tea (lower INR)
Diet: Vitamin K is warfarin’s direct antagonist. Foods high in vitamin K (leafy greens — spinach, kale, broccoli, Brussels sprouts) lower INR. The goal is consistency, not elimination — eat these foods regularly in similar amounts rather than avoiding them entirely
Alcohol: Heavy acute alcohol use raises INR; chronic heavy drinking lowers it
Illness: Fever, diarrhoea, reduced food intake all affect INR

Keeping a consistent dietary record in a Doctor Appointment Journal and noting any dose changes alongside your INR readings makes patterns much easier to spot — both for you and your anticoagulation team.

What to Bring to Your Anticoagulation Appointment

INR booklet or anticoagulation record card — most clinics issue these
Current warfarin dose (mg) and any dose changes since last visit
List of all medications and supplements — including anything started since your last test
Record of any bleeding symptoms (unusual bruising, nosebleeds, blood in urine or stool, prolonged bleeding from cuts)
Record of any missed doses

Signs to Report Urgently (Before Your Scheduled Appointment)

Unusual or heavy bleeding — gums, nose, prolonged from cuts
Blood in urine (pink/red/brown) or stools (black, tarry stools suggest GI bleeding)
Coughing or vomiting blood
Severe headache, vision changes, or sudden weakness — possible intracranial bleeding
Excessive bruising

Questions to Ask

Is my INR within my target range — and what is my target range?
Do I need a dose change, and by how much?
When should I retest after this dose change?
Is warfarin still the right anticoagulant for me, or should I be considered for a DOAC (direct oral anticoagulant)?
Are there any new medications I should flag before starting?

Warfarin vs DOACs

Direct oral anticoagulants (DOACs — apixaban, rivaroxaban, dabigatran, edoxaban) do not require INR monitoring and have fewer dietary interactions. For most patients with AF or DVT/PE, DOACs are now first-line. Warfarin remains preferred for mechanical heart valves and antiphospholipid syndrome. If you have been on warfarin for years and are wondering about switching, ask your doctor whether a DOAC is appropriate for your indication.

Regional Notes

Singapore: Anticoagulation clinics operate at all restructured hospitals. INR testing is available at polyclinic labs. Point-of-care INR testing (CoaguChek) is available for home monitoring. DOACs (apixaban, rivaroxaban) are on the subsidised drug list under relevant indications.

Australia: Anticoagulation management via GP or specialist. INR testing is bulk-billed at most pathology centres. Home INR monitoring devices are available and partially reimbursed for some indications. PBS subsidises warfarin; DOACs are PBS-subsidised for AF, DVT/PE.

United States: Anticoagulation clinics at major hospital systems. Point-of-care INR testing common. Medicare covers home INR monitoring for some mechanical valve patients. All major DOACs are FDA-approved and covered by most insurers for relevant indications.

KEY SOURCES

RELATED GUIDES

Medical Disclaimer: This guide is for informational and preparation purposes only. It does not constitute medical advice, diagnosis, or treatment. Always consult a qualified medical professional for guidance specific to your situation.